Please assess the completion status of the following clinical trial:

Trial Title: Superiority of MACI® Versus Microfracture Treatment in Patients With Symptomatic Articular Cartilage Defects in the Knee

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement~Exclusion Criteria:~* Known history of hypersensitivity to gentamicin, other aminoglycosides, or products of porcine or bovine origin~* Severe osteoarthritis of the knee~* Inflammatory arthritis, inflammatory joint disease, or uncorrected congenital blood coagulation disorders~* Prior knee surgery (within 6 months), excluding surgery to procure a biopsy or a concomitant procedure to prepare the knee for a MACI implant.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- MACI (Type: EXPERIMENTAL): autologous cultured chondrocytes on porcine collagen membrane
- Microfracture (Type: ACTIVE_COMPARATOR): Microfracture

Based on this trial design, predict the completion outcome and termination type (if applicable).